quality control standards for cancer registration throughout Europe, preparing the way for EUROCARE, which has accumulated data from 67 populationbased cancer registries in more than 20 countries.
The EC's Public Health Directorate has become the enemy of many of Europe's cancer scientists for its funding decision. But Boyle said that the directorate is aware that a public health approach has been successful and remains important. "Unfortunately, it appears that their hands have been somewhat tied by the legislation authorizing the distribution of the funding available," he said. "Until recently they've been outstanding in funding major public health networks and initiatives."
The funding decisions highlight the inevitable conflict between scientific objectives and other public priorities within the institutional triangle that lies at the heart of this unique brand of policy making: The European Commission includes 17,000 officials headed by 20 commissioners, including a health policy commissioner; the European Parliament has more than 600 members, directly elected every 5 years; and the Council of Ministers represents the governments of all member states and its approval is required for all major decisions.
In theory, the EC proposes law and policy and the Parliament and Council approve them. In practice, the EC needs support from the other two bodies to launch major new projects.
When Karin Jöns, a German member of the European Parliament and chair of the European Parliamentary Group on Breast Cancer, protested against not funding the projects, she said that she was told that the EU had made "a massive investment" in cancer over the previous 15 years compared with other major public health issues. Cancer epidemiology was "the most developed area of health statistics" and cancer networks were not seen as a priority. Health Commissioner David Byrne said that the EU had decided to focus "some of the limited resources in areas where the situation was at a critical embryonic stage, like cardiovascular disease, diabetes, and mental health."
Boyle disputes this reasoning. "The results achieved by Europe Against Cancer in the field of tobacco legislation will have a great impact on a wide variety of diseases apart from cancer," he said. In addition, he said, EPIC is an essential resource for investigating associations among nutrition, other lifestyle factors, and a variety of common, chronic diseases in addition to cancer. "Why stop public health activities which have been demonstrated to have a direct benefit on the health of the European citizen?" Sullivan agreed that funding has to be seen as a long-term investment. "People in politics tend to assume that once something has been done, the relevant box can be ticked, and that it's time to move onto to something else," he said. "I don't think they're unusual here, but they need to get the balance right between cancer, cardiovascular, and other kinds of disease."
He noted that projects can still receive funding from EU member states (25 countries in May 2004). However, "When EUROCARE was cut off at the knees, it was told to go to member states for money but, in effect, the member states said: 'Don't be ridiculous. This is a European issue.'" The EC's Public Health Directorate will accept a second round of submissions for project grants this year, said Max Parkin, M.D., Ph.D., who coordinates the ENCR. "It could be that next time around, they will be sympathetic to cancer projects," he said. "But the earliest any new funding would be available would be the beginning of 2005." "Without additional funding the registries run by individual member states will continue to operate, but without ENCR support," added Parkin, who is based at IARC in Lyon. "Several scientists have already lost their jobs." Boyle believes this target was realistic despite demographic changes that will result in 22% more people older than age 65 and 50% more people older than age 85 in the EU by 2015. But now, he said, "With the recent changes in program priories within public health, it is not clear how this target will be achieved."
A $400 million EU action plan to create a "healthier Europe" is replacing a series of eight so-called "issue specific" programs, each focusing on individual health issues. One was dedicated to cancer. The EC claims that this old approach led to "fragmentation of effort."
The new action plan has three priority areas: improving health information; improving reaction to health threats; and promoting "health determinants" such as tobacco control, nutrition, and physical activity.
-John Illman
